数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

股本结构

单位:万股
公告日期 2023-12-28 2023-11-13 2023-08-11 2023-05-12 2023-03-30 2023-03-30
证券总股本 104.18 2083.66 2614.34 2612.67 2612.67 2604.34
普通股本 104.18 2083.66 2614.34 2612.67 2612.67 2604.34
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-01-02 2023-09-30 2023-06-30 2023-03-31 2023-03-30 2022-12-31
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2023-12-28 104.18 未披露
更多>>
On December 28, 2023, Pasithea Therapeutics Corp. reflecting a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 (the “Common Stock”), to be effected at 12:01 a.m. Eastern Time on January 2, 2024.
2024-01-02
2023-11-13 2083.66 未披露
更多>>
From June 30, 2023 to September 30, 2023 Stock-based compensation: -restricted share units Stock repurchase
2023-09-30
2023-08-11 2614.34 未披露
更多>>
From March 31, 2023 to June 30, 2023 Stock-based compensation: -restricted share units
2023-06-30
2023-05-12 2612.67 未披露
更多>>
From January 1, 2023 to March 31, 2023 restricted share units
2023-03-31
2023-03-30 2612.67 未披露 定期报告 2023-03-30
2023-03-30 2604.34 未披露
更多>>
From December 31, 2021 to December 31, 2022 Common shares and warrants issued for acquisition Common shares and warrants issued for acquisition of intangible assets Shares repurchased in litigation settlement Shares issued for services
2022-12-31
2022-11-15 2924.87 未披露 定期报告 2022-11-09
2022-08-15 2669.87 未披露
更多>>
From March 31, 2022 to June 30, 2022 Common share issued for acquisition Shares issued for services
2022-06-30
2022-06-29 2654.87 未披露 定期报告 2022-06-22
2022-05-16 2328.78 未披露 定期报告 2022-05-09
2022-05-16 2300.84 未披露 定期报告 2022-03-31
2022-03-30 2285.84 未披露 定期报告 2022-03-23
2022-03-30 2300.84 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of shares for cash Issuance of shares for services Share adjustment Sale of Units, net of underwriting discounts and offering costs Sale of common stock and warrants, net of fees and costs Exercise of warrants for cash
2021-12-31
2021-12-09 2188.84 未披露 定期报告 2021-12-08
2021-11-18 1320.84 未披露
更多>>
From June 30, 2021 to September 30, 2021 Shares issued for services Sale of 4,800,000 Units, net of underwriting discounts and offering costs
2021-09-30
2021-09-16 1305.84 未披露
更多>>
1.Units offered by company 4,800,000 Units 2.The number of shares of Common Stock to be outstanding after this offering is based on 8,258,371 shares of Common Stock outstanding as of August 24, 2021
2021-09-15
On December 28, 2023, Pasithea Therapeutics Corp. reflecting a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 (the “Common Stock”), to be effected at 12:01 a.m. Eastern Time on January 2, 2024.
From June 30, 2023 to September 30, 2023 Stock-based compensation: -restricted share units Stock repurchase
From March 31, 2023 to June 30, 2023 Stock-based compensation: -restricted share units
From January 1, 2023 to March 31, 2023 restricted share units
From December 31, 2021 to December 31, 2022 Common shares and warrants issued for acquisition Common shares and warrants issued for acquisition of intangible assets Shares repurchased in litigation settlement Shares issued for services
From March 31, 2022 to June 30, 2022 Common share issued for acquisition Shares issued for services
From December 31, 2020 to December 31, 2021 Issuance of shares for cash Issuance of shares for services Share adjustment Sale of Units, net of underwriting discounts and offering costs Sale of common stock and warrants, net of fees and costs Exercise of warrants for cash
From June 30, 2021 to September 30, 2021 Shares issued for services Sale of 4,800,000 Units, net of underwriting discounts and offering costs
1.Units offered by company 4,800,000 Units 2.The number of shares of Common Stock to be outstanding after this offering is based on 8,258,371 shares of Common Stock outstanding as of August 24, 2021